海正药业：广州医药成为省医药公司100%股权受让方，交易价格为8600万元

Core Viewpoint - Haizheng Pharmaceutical (600267.SH) has confirmed that Guangzhou Medicine is the buyer in a property rights transaction, with a deposit of RMB 86 million paid for the acquisition of 100% equity in Zhejiang Pharmaceutical Industry Co., Ltd [1] Group 1 - The transaction is based on the "Entrusted Transfer Service Agreement," "Bidding and Commitment," and "Online Bidding Trading Instructions" [1] - The transaction notification was issued by the Taiwan Stock Exchange on December 10, 2025 [1]